Full Text View
Tabular View
No Study Results Posted
Related Studies
N-Acetylcysteine to Prevent Radiocontrast Nephropathy in Emergency Department Patients
The recruitment status of this study is unknown because the information has not been verified recently.
Verified October 2008 by Beth Israel Deaconess Medical Center.
Recruitment status was  Recruiting
Study NCT00780962   Information provided by Beth Israel Deaconess Medical Center

First Received on October 27, 2008.   No Changes Posted
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Radiocontrast Nephropathy
Additional conditions recognized in this trial
Emergencies
Kidney Diseases
More general conditions related to this trial
Disease Attributes
Pathologic Processes
Urologic Diseases
Interventions listed in this trial
N-Acetycysteine (NAC)
Additional drug interventions recognized in this trial
Acetylcysteine
N-monoacetylcystine
More general drug interventions related to this trial
Anti-Infective Agents
Antidotes
Antioxidants
Antiviral Agents
Expectorants
Free Radical Scavengers
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs
Protective Agents
Respiratory System Agents
Therapeutic Uses
Sponsors listed in this trial
Beth Israel Deaconess Medical Center
Cumberland Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services